• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
#

Pharmaceutical Companies

: 104
UBS no longer advises buying shares in the maker of Ozempic. Is it inferior to a competitor?
News·06.08.2025 00:15
UBS no longer advises buying shares in the maker of Ozempic. Is it inferior to a competitor?
  • LLY
  • NOVO-B.CO
Pharma stocks plummet after Trumps demand for price cuts. Should we be worried?
News·01.08.2025 03:07
Pharma stocks plummet after Trump's demand for price cuts. Should we be worried?
  • LLY
  • NVO
  • PFE
Shares in biotech Sarepta soar after FDA allows shipments of Elevidys to resume
Small Caps·30.07.2025 11:46
Shares in biotech Sarepta soar after FDA allows shipments of Elevidys to resume
  • SRPT
Novo Nordisk shares are having their worst day in almost 40 years. The company downgraded its outlook again
News·29.07.2025 21:37
Novo Nordisk shares are having their worst day in almost 40 years. The company downgraded its outlook again
  • NOVO-B.CO
  • LLY
After third patient death this year, HC Wainwright cuts TP on Sarepta to zero
Small Caps·22.07.2025 13:20
After third patient death this year, HC Wainwright cuts TP on Sarepta to zero
  • SRPT
Business in the age of Ozempic: who will benefit from the growing popularity of weight loss drugs
Review·19.07.2025 15:02
Business in the age of Ozempic: who will benefit from the growing popularity of weight loss drugs
  • NVO
  • LLY
  • NESN.SW
Pandemic pets taken from shelters are aging out. Which company will capitalize on this?
News·16.07.2025 18:38
Pandemic pets taken from shelters are aging out. Which company will capitalize on this?
  • CHWY
Biotech ProKidney soars 500% after positive trial results, but analysts are cautious
Small Caps·09.07.2025 17:30
Biotech ProKidney soars 500% after positive trial results, but analysts are cautious
  • PROK
Freedom Broker says buy Hims & Hers after cancellation of tie-up with Novo Nordisk
Small Caps·01.07.2025 17:47
Freedom Broker says buy Hims & Hers after cancellation of tie-up with Novo Nordisk
  • HIMS
China approves Ozempics first domestic competitor. What do investors need to know?
News·30.06.2025 17:50
China approves Ozempic's first domestic competitor. What do investors need to know?
  • NOVO-B.CO
  • LLY
Eli Lilly is entering a market valued at $30 billion, can it beat the competition?
News·24.06.2025 04:17
Eli Lilly is entering a market valued at $30 billion, can it beat the competition?
  • LLY
  • NVO
  • AZN
Novo Nordisk shares recovered after the collapse. What will happen to the company next?
News·17.06.2025 21:00
Novo Nordisk shares recovered after the collapse. What will happen to the company next?
  • NVO
Load more
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026